Drug Search Results
More Filters [+]

Poliglusam

Alternative Names: poliglusam, chitosan, celox
Latest Update: 2024-12-04
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: TCR Activator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Topical,Oral,Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Brazil | Chile | Colombia | Dominican Republic | India | Malaysia | Peru | Philippines | Sri Lanka | Turkey | United Arab Emirates

Approved Indications: None

Known Adverse Events: None

Company: EskeC
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Poliglusam

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Mandibular Diseases|Anesthesia Related|Facial Pain|Inflammation|Poroma|Pain, Postoperative|Osteoarthritis, Knee|Neck Pain|Uterine Hemorrhage

Phase 3: Genital Diseases, Female|Pain, Postoperative|Pulpitis|Dental Caries|Mandibular Fractures|Diabetic Foot

Phase 2: Pulpitis|Dermatitis, Atopic|Environmental Hypersensitivity|Nasal Obstruction|Lacrimal Duct Obstruction|Hypercholesterolemia|Keratoconjunctivitis Sicca|Prostate Cancer|Dry Eye Syndromes|Dental Caries|Sinusitis|Intestinal Diseases|Chronic Pain|Stomatitis, Aphthous

Phase 1: Keratoconjunctivitis Sicca|Periodontal Diseases|Dry Eye Syndromes|Liver Cirrhosis|Psoriasis|Blind Loop Syndrome|Dacryocystitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR2200058309

N/A

Recruiting

Infertility

2040-05-01

ChiCTR2300078627

N/A

Recruiting

Injuries/wounds Unspecified

2027-11-01

ChiCTR2400093518

N/A

Not yet recruiting

Unknown

2027-09-30

ChiCTR2400086094

N/A

Not yet recruiting

Oral Ulcer

2026-12-31

Recent News Events